BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32142169)

  • 1. Multimodal Imaging With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging to Detect Extracapsular Extension in Head and Neck Cancer.
    Sheppard SC; Giger R; Bojaxhiu B; Sachpekidis C; Dammann F; Dettmer MS; Arnold A; Wartenberg J; Nisa L
    Laryngoscope; 2021 Jan; 131(1):E163-E169. PubMed ID: 32142169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of
    Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
    Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma.
    Rohde M; Nielsen AL; Pareek M; Johansen J; Sørensen JA; Diaz A; Nielsen MK; Christiansen JM; Asmussen JT; Nguyen N; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
    J Nucl Med; 2019 May; 60(5):592-599. PubMed ID: 30315144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Value of FDG-PET/CT for the Identification of Extranodal Extension in Patients With Head and Neck Squamous Cell Carcinoma.
    Toya R; Saito T; Matsuyama T; Kai Y; Shiraishi S; Murakami D; Yoshida R; Watakabe T; Sakamoto F; Tsuda N; Arimura H; Orita Y; Nakayama H; Oya N
    Anticancer Res; 2020 Apr; 40(4):2073-2077. PubMed ID: 32234899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/CT Poorly Predicts AJCC 8th Edition Pathologic Staging in HPV-Related Oropharyngeal Cancer.
    Snyder V; Goyal LK; Bowers EMR; Kubik M; Kim S; Ferris RL; Johnson JT; Duvvuri U; Gooding WE; Branstetter BF; Rath TJ; Sridharan SS
    Laryngoscope; 2021 Jul; 131(7):1535-1541. PubMed ID: 33428218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of diffusion-weighted imaging and
    Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
    Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of CT, MRI, and PET-CT in detecting retropharyngeal lymph node metastasis of head and neck squamous cell carcinoma.
    Kim JH; Choi KY; Lee SH; Lee DJ; Park BJ; Yoon DY; Rho YS
    BMC Med Imaging; 2020 Jul; 20(1):88. PubMed ID: 32727384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?
    Dejaco D; Uprimny C; Widmann G; Riedl D; Moser P; Arnold C; Steinbichler TB; Kofler B; Schartinger VH; Virgolini I; Riechelmann H
    Cancer Imaging; 2020 Sep; 20(1):69. PubMed ID: 32993805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A gradient mapping guided explainable deep neural network for extracapsular extension identification in 3D head and neck cancer computed tomography images.
    Wang Y; Rahman A; Duggar WN; Thomas TV; Roberts PR; Vijayakumar S; Jiao Z; Bian L; Wang H
    Med Phys; 2024 Mar; 51(3):2007-2019. PubMed ID: 37643447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of extranodal extension in oropharyngeal cancer patients and carcinoma of unknown primary: value of metabolic tumor imaging with hybrid PET compared with MRI and CT.
    Nemmour A; Stadler TM; Maurer A; Kovacs Z; Serrallach B; Born D; Nemes CM; Broglie MA; Pazahr S; Rupp NJ; Hüllner MW; Stoeckli SJ; Morand GB
    Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1973-1981. PubMed ID: 36471046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-Institutional Validation of Deep Learning for Pretreatment Identification of Extranodal Extension in Head and Neck Squamous Cell Carcinoma.
    Kann BH; Hicks DF; Payabvash S; Mahajan A; Du J; Gupta V; Park HS; Yu JB; Yarbrough WG; Burtness BA; Husain ZA; Aneja S
    J Clin Oncol; 2020 Apr; 38(12):1304-1311. PubMed ID: 31815574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
    Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
    Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of only 18F-fluorodeocyglucose positron emission tomography/computed tomography-positive lymph nodes in head and neck squamous cell carcinoma.
    Lee SH; Huh SH; Jin SM; Rho YS; Yoon DY; Park CH
    Otolaryngol Head Neck Surg; 2012 Oct; 147(4):692-8. PubMed ID: 22535915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of PET/CT on Staging and Treatment of Advanced Head and Neck Squamous Cell Carcinoma.
    Jorgensen JB; Smith RB; Coughlin A; Spanos WC; Lohr MM; Sperry SM; Militsakh O; Zitsch RP; Yueh B; Dooley LM; Panwar A; Galloway TLI; Pagedar NA
    Otolaryngol Head Neck Surg; 2019 Feb; 160(2):261-266. PubMed ID: 30126337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A PET/CT-Based Strategy Is a Stronger Predictor of Survival Than a Standard Imaging Strategy in Patients with Head and Neck Squamous Cell Carcinoma.
    Rohde M; Nielsen AL; Pareek M; Johansen J; Sørensen JA; Diaz A; Nielsen MK; Christiansen JM; Asmussen JT; Nguyen N; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
    J Nucl Med; 2018 Apr; 59(4):575-581. PubMed ID: 28864630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-fluoro-deoxy-glucose-positron emission tomography/computed tomography in diagnosis of head and neck squamous cell carcinoma: a systematic review and meta-analysis.
    Rohde M; Dyrvig AK; Johansen J; Sørensen JA; Gerke O; Nielsen AL; Høilund-Carlsen PF; Godballe C
    Eur J Cancer; 2014 Sep; 50(13):2271-9. PubMed ID: 25011659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-look PET-CT following an initial incomplete PET-CT response to (chemo)radiotherapy for head and neck squamous cell carcinoma.
    Prestwich RJD; Arunsingh M; Zhong J; Dyker KE; Vaidyanathan S; Scarsbrook AF
    Eur Radiol; 2020 Feb; 30(2):1212-1220. PubMed ID: 31485835
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Kim SA; Roh JL; Kim JS; Lee JH; Lee SH; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2017 Feb; 72():62-70. PubMed ID: 28027517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.
    Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK
    J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.